Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tele-rehabilitation after intracerebral transplantation of autologous bone marrow stromal cells with recombinant peptide scaffold in chronic intracerebral hemorrhage
jRCT1010240041Active, not recruiting
- Sponsor
- Masahito Kawabori
- Start
- Nov 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow stromal cells in intracerebral hemorrhage (ICH), sponsored by Masahito Kawabori. Primary endpoint: Safety of tele-rehabilitation. Started Nov 2024; status: active, not recruiting.
02
Drugs
autologous bone marrow stromal cells
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on jRCT1010240041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1010240041.